{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:36:26Z","timestamp":1768415786241,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02792-z","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T02:02:31Z","timestamp":1679709751000},"page":"747-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Atrial fibrillation risk on Parkinson\u2019s disease \u2013 a systematic review and meta-analysis"],"prefix":"10.1007","volume":"55","author":[{"given":"F\u00e1tima","family":"Cereja","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Joaquim J","family":"Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-5673","authenticated-orcid":false,"given":"Daniel","family":"Caldeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"2792_CR1","doi-asserted-by":"crossref","unstructured":"Kalia LV, Lang AE (2015 Aug) Parkinson\u2019s disease. The Lancet 29(9996):896\u2013912","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"2792_CR2","doi-asserted-by":"crossref","unstructured":"Hong CT, Chan L, Wu D, Chen WT, Chien LN (2019) Association between Parkinson\u2019s disease and atrial fibrillation: a population-based study.Front Neurol; 10","DOI":"10.3389\/fneur.2019.00022"},{"key":"2792_CR3","doi-asserted-by":"crossref","unstructured":"Alves M, Caldeira D, Ferro JM, Ferreira JJ (2020) Does Parkinson\u2019s disease increase the risk of cardiovascular events? A systematic review and meta-analysis.Eur J Neurol; 27","DOI":"10.1111\/ene.14125"},{"key":"2792_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/eci.13174","volume":"49","author":"AA Khan","year":"2019","unstructured":"Khan AA, Lip GYH, Shantsila A (2019) Heart rate variability in atrial fibrillation: the balance between sympathetic and parasympathetic nervous system. Eur J Clin Invest 49:1\u20138","journal-title":"Eur J Clin Invest"},{"key":"2792_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/ene.13398","volume":"24","author":"TH Mertsalmi","year":"2017","unstructured":"Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2017) More than constipation \u2013 bowel symptoms in Parkinson\u2019s disease and their connection to gut microbiota. Eur J Neurol 24:1375\u20131383","journal-title":"Eur J Neurol"},{"key":"2792_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000338610","volume":"12","author":"J S\u0142awek","year":"2013","unstructured":"S\u0142awek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Go\u0142a\u0327b-Janowska M, Koziorowska-Gawron E, Dro\u017adzik M, Kurzawski M, Bandurski T, Bia\u0142ecka M (2013) The impact of MRI white matter hyperintensities on dementia in parkinson\u2019s disease in relation to the homocysteine level and other vascular risk factors. Neurodegener Dis 12:1\u201312","journal-title":"Neurodegener Dis"},{"key":"2792_CR7","doi-asserted-by":"publisher","first-page":"116949","DOI":"10.1016\/j.jns.2020.116949","volume":"415","author":"JH Won","year":"2020","unstructured":"Won JH, Byun SJ, Oh BM, Kim HJ, Park SJ, Seo HG (2020) Pneumonia risk and its associated factors in Parkinson\u2019s disease: a National Database Study. J Neurol Sci 415:116949","journal-title":"J Neurol Sci"},{"key":"2792_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.STR.23.6.839","volume":"23","author":"RL Levine","year":"1992","unstructured":"Levine RL, Jones JC, Bee N (1992) Stroke and Parkinson\u2019s Disease. Stroke 23:839\u2013843","journal-title":"Stroke"},{"key":"2792_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/acn3.51279","volume":"8","author":"S Han","year":"2021","unstructured":"Han S, Moon I, Choi EK, Han K, Do, Cho HC, Lee SY, Yang S, Kwon S, Choi Y, jung, Lee HJ, Lee E, Lee SR, Oh S (2021) Increased atrial fibrillation risk in Parkinson\u2019s disease: a nationwide population-based study. Ann Clin Transl Neurol 8:238\u2013246","journal-title":"Ann Clin Transl Neurol"},{"key":"2792_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/WAD.0000000000000138","volume":"30","author":"BN Dugger","year":"2016","unstructured":"Dugger BN, Malek-Ahmadi M, Monsell SE, Kukull WA, Woodruff BK, Reiman EM, Beach TG, Wilson J (2016) A cross-sectional analysis of late-life cardiovascular factors and their relation to clinically defined neurodegenerative diseases. Alzheimer Dis Assoc Disord 30:223\u2013229","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2792_CR11","doi-asserted-by":"crossref","unstructured":"Shindo K, Morishima Y, Suwa Y, Fukao T, Kurita T, Satake A, Tsuchiya M, Ichinose Y, Hata T, Koh K, Nagasaka T, Takiyama Y Age-related changes in blood pressure and heart rates of patients with Parkinson\u2019s disease.The Journal of Clinical Hypertension2020:jch.14096","DOI":"10.1111\/jch.14096"},{"key":"2792_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/JPD-191907","volume":"10","author":"M Alves","year":"2020","unstructured":"Alves M, Caldeira D, Leal Rato M, Duarte GS, Ferreira AN, Ferro JM, Ferreira JJ (2020) Cardiovascular adverse events reported in Placebo Arm of Randomized controlled trials in Parkinson\u2019s Disease. J Parkinsons Dis 10:641\u2013651","journal-title":"J Parkinsons Dis"},{"key":"2792_CR13","doi-asserted-by":"crossref","unstructured":"\u00c7anga Y, Emre A, Y\u00fcksel GA, Karata\u015f MB, Yelge\u00e7 NS, G\u00fcrkan U, \u00c7alik AN, Tireli H, Terzi S (2018) Assessment of atrial conduction times in patients with newly diagnosed Parkinson\u2019s disease. Parkinsons Dis ;2018","DOI":"10.1155\/2018\/2916905"},{"key":"2792_CR14","doi-asserted-by":"publisher","first-page":"633900","DOI":"10.3389\/fneur.2021.633900","volume":"12","author":"M Alves","year":"2021","unstructured":"Alves M, Abrantes AM, Portugal G, Cruz MM, Reim\u00e3o S, Caldeira D, Ferro JM, Ferreira JJ (2021) Does Parkinson\u2019s disease increase the risk of Atrial Fibrillation? Insights from Electrocardiogram and Risk Scores from a case-control study. Front Neurol 12:633900","journal-title":"Front Neurol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02792-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:59:22Z","timestamp":1682740762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02792-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02792-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"5 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Cereja reports no conflict of interest. Dr Alves reports participation in conferences with Boehringer-Ingelheim, AstraZeneca, Bayer, Bristol-Myers-Squibb, Grunenthal, Tecnimede, Merck Sharp & Dohme. Professor Caldeira reports participation in conferences with Bristol-Myers-Squibb, Bayer, Boheringer Ingelheim, Daiichi-Sankyo, Merck-Serono, Ferrer, Pfizer,Novartis, Roche. Professor Ferreira reports personal fees from Grunenthal, Fundacao MSD (Portugal), TEVA, MSD, Allergan, Medtronic, GlaxoSmithKline, Novartis, Lundbeck, Solvay, BIAL, Merck-Serono, Merz, Ipsen, Biogen, Acadia, Allergan, Abbvie, Sunovion-Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent optional"}}]}}